Poltreg S.A.
PTG | WAR
Overview
Corporate Details
- ISIN(s):
- PLPLTRG00012 (+2 more)
- LEI:
- 259400XSAJTERJ42VZ86
- Country:
- Poland
- Address:
- GDAŃSK BOTANICZNA 20, 80-298 GDAŃSK
- Website:
- https://poltreg.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Poltreg S.A. is a biotechnology company based in Poland that focuses on developing innovative therapies for autoimmune diseases. The company specializes in using T-regulatory cells (TREGs) to develop a new generation of medicines aimed at treating autoimmune diseases , such as diabetes type 1 and multiple sclerosis. Poltreg S.A. is currently conducting various stages of research and development projects in these areas to offer medical solutions to those suffering from autoimmune diseases . The company's strong commitment to research and development is reinforced by its team of qualified scientists and researchers dedicated to developing new technologies and techniques to improve health outcomes.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-13 15:56 |
Capital/Financing Update
Rejestracja spółki zależnej Immuthera w USA - Content (PL)
|
Polish | 784 bytes | |
| 2025-05-21 12:30 |
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Zgromadze…
|
Polish | 2.3 KB | |
| 2025-05-20 22:12 |
Regulatory News Service
Warunkowe przyznanie patentu przez Australijski Urząd Patentowy w projekcie ter…
|
Polish | 1.4 KB | |
| 2025-05-20 22:12 |
Regulatory News Service
Warunkowe przyznanie patentu przez Australijski Urząd Patentowy w projekcie ter…
|
Polish | 1.3 KB | |
| 2025-05-20 15:45 |
Remuneration Report
Sprawozdanie RN o wynagrodzeniach
|
Polish | 1.2 MB | |
| 2025-05-20 15:45 |
Declaration of Voting Results & Voting Rights Announcements
Podjęte Uchwały
|
Polish | 184.3 KB | |
| 2025-05-20 15:45 |
Declaration of Voting Results & Voting Rights Announcements
Treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie PolTREG S.A. w dniu 2…
|
Polish | 729 bytes | |
| 2025-05-19 23:25 |
Regulatory News Service
Warunkowe przyznanie patentu przez Japoński Urząd Patentowy w projekcie terapii…
|
Polish | 1.6 KB | |
| 2025-05-19 11:17 |
Board/Management Change
CV
|
Polish | 1.2 MB | |
| 2025-05-19 11:17 |
Board/Management Change
Zgłoszenie kandydata na Członka Rady Nadzorczej PolTREG S.A. - Content (PL)
|
Polish | 1.7 KB | |
| 2025-05-18 23:25 |
Regulatory News Service
Warunkowe przyznanie patentu przez Japoński Urząd Patentowy w projekcie terapii…
|
Polish | 1.5 KB | |
| 2025-05-14 17:20 |
Quarterly Report
Raport kwartalny 1Q 2025
|
Polish | 4.4 MB | |
| 2025-05-06 10:53 |
Regulatory News Service
Otrzymanie pozytywnej opinii od Komitetu Pediatrycznego Europejskiej Agencji Le…
|
Polish | 1.3 KB | |
| 2025-05-05 10:13 |
Inside Information Statement
Otrzymanie raportu z części in vivo badań na zwierzętach w programie terapii CA…
|
Polish | 1.0 KB | |
| 2025-04-29 16:01 |
Regulatory News Service
Negatywna ocena projektu badawczo-rozwojowego PolTREG S.A. przez Polską Agencję…
|
Polish | 1.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
GenSight Biologics S.A. | France | SIGHT | |
|
Gentian Diagnostics ASA | Norway | GENT | |
|
Genus PLC | United Kingdom | GNS | |
|
Grace Breeding Ltd. | Israel | GRAC | |
|
Group 107 Ltd. | Israel | G107 | |
|
Guard Therapeutics International AB | Sweden | GUARD | |
|
Gubra A/S | Denmark | GUBRA | |
|
Hadasit Bio Holding Ltd. | Israel | HDST-M | |
|
Hansa Biopharma | Sweden | HNSA | |
|
HEMOGENYX PHARMACEUTICALS PLC | United Kingdom | HEMO |